ID APAF_MOUSE Reviewed; 1249 AA. AC O88879; A2RRK8; DT 23-JAN-2002, integrated into UniProtKB/Swiss-Prot. DT 27-JUL-2011, sequence version 3. DT 24-JAN-2024, entry version 190. DE RecName: Full=Apoptotic protease-activating factor 1; DE Short=APAF-1; GN Name=Apaf1; OS Mus musculus (Mouse). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae; OC Murinae; Mus; Mus. OX NCBI_TaxID=10090; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC STRAIN=Swiss Webster / NIH; TISSUE=Embryo; RX PubMed=9753320; DOI=10.1016/s0092-8674(00)81732-8; RA Cecconi F., Alvarez-Bolado G., Meyer B.I., Roth K.A., Gruss P.; RT "Apaf1 (CED-4 homolog) regulates programmed cell death in mammalian RT development."; RL Cell 94:727-737(1998). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2). RC TISSUE=Spleen; RX PubMed=11119689; DOI=10.1016/s0006-8993(00)02916-4; RA Walke D.W., Morgan J.I.; RT "A comparison of the expression and properties of Apaf-1 and Apaf-1L."; RL Brain Res. 886:73-81(2000). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1). RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP INTERACTION WITH APIP, AND DOMAIN. RX PubMed=15262985; DOI=10.1074/jbc.m405747200; RA Cho D.-H., Hong Y.-M., Lee H.-J., Woo H.-N., Pyo J.-O., Mak T.W., RA Jung Y.-K.; RT "Induced inhibition of ischemic/hypoxic injury by APIP, a novel Apaf-1- RT interacting protein."; RL J. Biol. Chem. 279:39942-39950(2004). RN [5] RP INTERACTION WITH UACA. RX PubMed=15271982; DOI=10.1074/jbc.m402902200; RA Sakai T., Liu L., Teng X., Mukai-Sakai R., Shimada H., Kaji R., Mitani T., RA Matsumoto M., Toida K., Ishimura K., Shishido Y., Mak T.W., Fukui K.; RT "Nucling recruits Apaf-1/pro-caspase-9 complex for the induction of stress- RT induced apoptosis."; RL J. Biol. Chem. 279:41131-41140(2004). RN [6] RP IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. RC TISSUE=Lung, Spleen, and Testis; RX PubMed=21183079; DOI=10.1016/j.cell.2010.12.001; RA Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R., RA Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.; RT "A tissue-specific atlas of mouse protein phosphorylation and expression."; RL Cell 143:1174-1189(2010). RN [7] RP X-RAY CRYSTALLOGRAPHY (3.0 ANGSTROMS), WD REPEATS, SUBUNIT, AND MUTAGENESIS RP OF ARG-265. RX PubMed=21827944; DOI=10.1016/j.str.2011.05.013; RA Reubold T.F., Wohlgemuth S., Eschenburg S.; RT "Crystal structure of full-length Apaf-1: how the death signal is relayed RT in the mitochondrial pathway of apoptosis."; RL Structure 19:1074-1083(2011). CC -!- FUNCTION: Oligomeric Apaf-1 mediates the cytochrome c-dependent CC autocatalytic activation of pro-caspase-9 (Apaf-3), leading to the CC activation of caspase-3 and apoptosis. This activation requires ATP (By CC similarity). {ECO:0000250}. CC -!- SUBUNIT: Monomer. Oligomerizes to a heptameric ring, known as the CC apoptosome, upon binding of cytochrome c and dATP. Oligomeric Apaf-1 CC and pro-caspase-9 bind to each other via their respective NH2-terminal CC CARD domains and consecutively mature caspase-9 is released from the CC complex (By similarity). Interacts with UACA. It may also interact with CC Bcl-XL. Interacts with APIP. Interacts (via CARD and NACHT domains) CC with NAIP/BIRC1 (via NACHT domain) (By similarity). Interacts with CC CIAO2A (By similarity). {ECO:0000250|UniProtKB:O14727}. CC -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; Synonyms=Apaf-1L; CC IsoId=O88879-1; Sequence=Displayed; CC Name=2; CC IsoId=O88879-2; Sequence=VSP_006763; CC -!- TISSUE SPECIFICITY: Highly expressed in lung and spleen, weakly in CC brain and kidney and not detectable in liver. CC -!- DEVELOPMENTAL STAGE: High levels in embryonic brain and liver from 11.5 CC dpc to 17.5 dpc. CC -!- DOMAIN: The CARD domain mediates interaction with APIP. CC {ECO:0000269|PubMed:15262985}. CC -!- DOMAIN: The monomeric form is autoinhibited in a closed conformation CC through a bound ADP at the nucleotide binding site. Exchange of ADP for CC ATP and binding of cytochrome c trigger a large conformational change CC where the first WD repeat region swings out, allowing the NB-ARC domain CC to rotate and expose the contact areas for oligomerization. CC {ECO:0000269|PubMed:15262985}. CC -!- MISCELLANEOUS: Physiological concentrations of calcium ions negatively CC affect the assembly of apoptosome by inhibiting nucleotide exchange in CC the monomeric form. {ECO:0000250}. CC -!- MISCELLANEOUS: [Isoform 1]: Major isoform. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF064071; AAC62458.1; -; mRNA. DR EMBL; BC131683; AAI31684.1; -; mRNA. DR EMBL; BC131684; AAI31685.1; -; mRNA. DR CCDS; CCDS36030.1; -. [O88879-1] DR CCDS; CCDS70095.1; -. [O88879-2] DR RefSeq; NP_001036023.1; NM_001042558.1. [O88879-1] DR RefSeq; NP_033814.2; NM_009684.2. [O88879-1] DR PDB; 3SFZ; X-ray; 3.00 A; A=1-1249. DR PDB; 3SHF; X-ray; 3.55 A; A=1-1249. DR PDBsum; 3SFZ; -. DR PDBsum; 3SHF; -. DR AlphaFoldDB; O88879; -. DR SMR; O88879; -. DR BioGRID; 198139; 3. DR ComplexPortal; CPX-3824; Apoptosome. DR CORUM; O88879; -. DR IntAct; O88879; 1. DR STRING; 10090.ENSMUSP00000020157; -. DR iPTMnet; O88879; -. DR PhosphoSitePlus; O88879; -. DR EPD; O88879; -. DR MaxQB; O88879; -. DR PaxDb; 10090-ENSMUSP00000020157; -. DR PeptideAtlas; O88879; -. DR ProteomicsDB; 281790; -. [O88879-1] DR ProteomicsDB; 281791; -. [O88879-2] DR Pumba; O88879; -. DR Antibodypedia; 17738; 846 antibodies from 46 providers. DR DNASU; 11783; -. DR Ensembl; ENSMUST00000020157.13; ENSMUSP00000020157.7; ENSMUSG00000019979.13. [O88879-1] DR Ensembl; ENSMUST00000159110.8; ENSMUSP00000125291.2; ENSMUSG00000019979.13. [O88879-1] DR GeneID; 11783; -. DR KEGG; mmu:11783; -. DR UCSC; uc007gtg.1; mouse. [O88879-1] DR AGR; MGI:1306796; -. DR CTD; 317; -. DR MGI; MGI:1306796; Apaf1. DR VEuPathDB; HostDB:ENSMUSG00000019979; -. DR eggNOG; KOG4155; Eukaryota. DR eggNOG; KOG4658; Eukaryota. DR GeneTree; ENSGT00940000157710; -. DR InParanoid; O88879; -. DR OMA; YHMANAN; -. DR OrthoDB; 2995530at2759; -. DR PhylomeDB; O88879; -. DR TreeFam; TF323866; -. DR Reactome; R-MMU-111458; Formation of apoptosome. DR Reactome; R-MMU-111459; Activation of caspases through apoptosome-mediated cleavage. DR Reactome; R-MMU-6798695; Neutrophil degranulation. DR Reactome; R-MMU-9627069; Regulation of the apoptosome activity. DR BioGRID-ORCS; 11783; 3 hits in 76 CRISPR screens. DR ChiTaRS; Apaf1; mouse. DR PRO; PR:O88879; -. DR Proteomes; UP000000589; Chromosome 10. DR RNAct; O88879; Protein. DR Bgee; ENSMUSG00000019979; Expressed in granulocyte and 246 other cell types or tissues. DR ExpressionAtlas; O88879; baseline and differential. DR GO; GO:0043293; C:apoptosome; ISO:MGI. DR GO; GO:0005829; C:cytosol; IDA:MGI. DR GO; GO:0005634; C:nucleus; IDA:MGI. DR GO; GO:0032991; C:protein-containing complex; ISO:MGI. DR GO; GO:0043531; F:ADP binding; IEA:InterPro. DR GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW. DR GO; GO:0008656; F:cysteine-type endopeptidase activator activity involved in apoptotic process; IDA:MGI. DR GO; GO:0031072; F:heat shock protein binding; ISO:MGI. DR GO; GO:0042802; F:identical protein binding; IPI:MGI. DR GO; GO:0007420; P:brain development; IMP:MGI. DR GO; GO:0010659; P:cardiac muscle cell apoptotic process; ISO:MGI. DR GO; GO:0030154; P:cell differentiation; IEA:Ensembl. DR GO; GO:0071560; P:cellular response to transforming growth factor beta stimulus; ISO:MGI. DR GO; GO:0030900; P:forebrain development; IMP:MGI. DR GO; GO:0097193; P:intrinsic apoptotic signaling pathway; NAS:ComplexPortal. DR GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IMP:ParkinsonsUK-UCL. DR GO; GO:0001822; P:kidney development; IEA:Ensembl. DR GO; GO:0001843; P:neural tube closure; IMP:MGI. DR GO; GO:0051402; P:neuron apoptotic process; IGI:MGI. DR GO; GO:2001235; P:positive regulation of apoptotic signaling pathway; IGI:MGI. DR GO; GO:1902510; P:regulation of apoptotic DNA fragmentation; IGI:MGI. DR GO; GO:0001666; P:response to hypoxia; IEA:Ensembl. DR GO; GO:0007584; P:response to nutrient; IEA:Ensembl. DR CDD; cd08323; CARD_APAF1; 1. DR CDD; cd00200; WD40; 2. DR Gene3D; 1.25.40.370; -; 1. DR Gene3D; 1.10.533.10; Death Domain, Fas; 1. DR Gene3D; 1.10.8.430; Helical domain of apoptotic protease-activating factors; 1. DR Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1. DR Gene3D; 1.10.10.10; Winged helix-like DNA-binding domain superfamily/Winged helix DNA-binding domain; 1. DR Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 2. DR InterPro; IPR017251; Apaf-1. DR InterPro; IPR041452; APAF1_C. DR InterPro; IPR037963; APAF1_CARD_dom. DR InterPro; IPR048975; APAF1_WHD. DR InterPro; IPR042197; Apaf_helical. DR InterPro; IPR001315; CARD. DR InterPro; IPR011029; DEATH-like_dom_sf. DR InterPro; IPR020472; G-protein_beta_WD-40_rep. DR InterPro; IPR002182; NB-ARC. DR InterPro; IPR027417; P-loop_NTPase. DR InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf. DR InterPro; IPR019775; WD40_repeat_CS. DR InterPro; IPR036322; WD40_repeat_dom_sf. DR InterPro; IPR001680; WD40_rpt. DR InterPro; IPR036388; WH-like_DNA-bd_sf. DR PANTHER; PTHR22845; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; 1. DR PANTHER; PTHR22845:SF5; APOPTOTIC PROTEASE-ACTIVATING FACTOR 1; 1. DR Pfam; PF21296; APAF-1-like_WHD; 1. DR Pfam; PF17908; APAF1_C; 1. DR Pfam; PF00619; CARD; 1. DR Pfam; PF00931; NB-ARC; 1. DR Pfam; PF00400; WD40; 10. DR PIRSF; PIRSF037646; Apop_pept_activating-1; 1. DR PRINTS; PR00364; DISEASERSIST. DR PRINTS; PR00320; GPROTEINBRPT. DR SMART; SM00320; WD40; 13. DR SUPFAM; SSF47986; DEATH domain; 1. DR SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1. DR SUPFAM; SSF50978; WD40 repeat-like; 2. DR PROSITE; PS50209; CARD; 1. DR PROSITE; PS00678; WD_REPEATS_1; 4. DR PROSITE; PS50082; WD_REPEATS_2; 9. DR PROSITE; PS50294; WD_REPEATS_REGION; 1. DR Genevisible; O88879; MM. PE 1: Evidence at protein level; KW 3D-structure; Alternative splicing; Apoptosis; ATP-binding; Calcium; KW Cytoplasm; Nucleotide-binding; Reference proteome; Repeat; WD repeat. FT CHAIN 1..1249 FT /note="Apoptotic protease-activating factor 1" FT /id="PRO_0000050845" FT DOMAIN 1..90 FT /note="CARD" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00046" FT DOMAIN 106..415 FT /note="NB-ARC" FT REPEAT 613..652 FT /note="WD 1-1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REPEAT 655..694 FT /note="WD 1-2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REPEAT 697..738 FT /note="WD 1-3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REPEAT 741..780 FT /note="WD 1-4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REPEAT 796..837 FT /note="WD 1-5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REPEAT 838..877 FT /note="WD 1-6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REPEAT 880..910 FT /note="WD 1-7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REPEAT 922..958 FT /note="WD 2-1" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REPEAT 959..998 FT /note="WD 2-2" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REPEAT 1001..1040 FT /note="WD 2-3" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REPEAT 1042..1080 FT /note="WD 2-4" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REPEAT 1083..1122 FT /note="WD 2-5" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REPEAT 1125..1164 FT /note="WD 2-6" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REPEAT 1176..1213 FT /note="WD 2-7" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REPEAT 1214..1249 FT /note="WD 2-8" FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00221, FT ECO:0000269|PubMed:21827944" FT REGION 910..921 FT /note="Interpropeller linker" FT BINDING 154..161 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT /evidence="ECO:0000255" FT BINDING 265 FT /ligand="ATP" FT /ligand_id="ChEBI:CHEBI:30616" FT VAR_SEQ 99..110 FT /note="GKDTDGGITSFV -> A (in isoform 2)" FT /evidence="ECO:0000303|PubMed:11119689" FT /id="VSP_006763" FT MUTAGEN 265 FT /note="R->S: No stimulation of CASP9 activity." FT /evidence="ECO:0000269|PubMed:21827944" FT CONFLICT 209 FT /note="E -> D (in Ref. 1; AAC62458)" FT /evidence="ECO:0000305" FT CONFLICT 592 FT /note="R -> P (in Ref. 1; AAC62458)" FT /evidence="ECO:0000305" FT CONFLICT 710 FT /note="K -> S (in Ref. 1; AAC62458)" FT /evidence="ECO:0000305" FT HELIX 109..116 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 130..141 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 142..145 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 148..153 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 160..167 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 171..174 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 175..177 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 182..186 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 192..206 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 207..209 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 220..230 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 232..235 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 239..244 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 248..251 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 259..266 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 267..272 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 288..299 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 309..316 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 317..319 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 321..333 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 334..336 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 338..346 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 361..373 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 377..379 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 380..385 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 386..388 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 397..404 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 408..420 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 425..436 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 439..448 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 450..452 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 453..465 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 470..472 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 480..493 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 497..504 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 507..517 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 520..528 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 529..532 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 540..552 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 553..556 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 557..559 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 563..568 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 575..585 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 589..591 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 598..600 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 608..611 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 618..623 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 627..634 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 639..643 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 644..646 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 649..653 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 660..665 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 669..676 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 679..685 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 686..688 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 691..696 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 702..707 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 709..712 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 715..720 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 725..729 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 732..739 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 746..751 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 757..771 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 772..774 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 777..782 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 810..817 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 820..825 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 826..828 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 831..836 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 838..841 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 845..848 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 854..858 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 860..862 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 864..868 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 869..872 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 873..878 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 885..890 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 894..901 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 906..910 FT /evidence="ECO:0007829|PDB:3SFZ" FT HELIX 911..915 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 919..931 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 934..953 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 956..959 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 964..969 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 973..980 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 986..989 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 990..992 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 996..998 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1009..1011 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1013..1016 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1018..1021 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1023..1030 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 1032..1034 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1047..1052 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1054..1071 FT /evidence="ECO:0007829|PDB:3SFZ" FT TURN 1072..1075 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1079..1082 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1091..1093 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1095..1099 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1101..1103 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1114..1118 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1130..1135 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1137..1146 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1153..1159 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1183..1186 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1193..1203 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1205..1207 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1228..1230 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1233..1236 FT /evidence="ECO:0007829|PDB:3SFZ" FT STRAND 1242..1245 FT /evidence="ECO:0007829|PDB:3SFZ" SQ SEQUENCE 1249 AA; 141003 MW; AA639E407F9ABC24 CRC64; MDAKARNCLL QHREALEKDI KTSYIMDHMI SNGVLSVIEE EKVKSQATQY QRAAALIKMI LNKDNCAYIS FYNALLHEGY KDLAALLQSG LPLVSSSSGK DTDGGITSFV RTVLCEGGVP QRPVIFVTRK KLVHAIQQKL WKLNGEPGWV TIYGMAGCGK SVLAAEAVRD HSLLEGCFSG GVHWVSIGKQ DKSGLLMKLQ NLCMRLDQEE SFSQRLPLNI EEAKDRLRVL MLRKHPRSLL ILDDVWDPWV LKAFDNQCQI LLTTRDKSVT DSVMGPKHVV PVESGLGREK GLEILSLFVN MKKEDLPAEA HSIIKECKGS PLVVSLIGAL LRDFPNRWAY YLRQLQNKQF KRIRKSSSYD YEALDEAMSI SVEMLREDIK DYYTDLSILQ KDVKVPTKVL CVLWDLETEE VEDILQEFVN KSLLFCNRNG KSFCYYLHDL QVDFLTEKNR SQLQDLHRKM VTQFQRYYQP HTLSPDQEDC MYWYNFLAYH MASANMHKEL CALMFSLDWI KAKTELVGPA HLIHEFVAYR HILDEKDCAV CENFQEFLSL NGHLLGRQPF PNIVQLGLCE PETSEVYRQA KLQAKQEGDT GRLYLEWINK KTIKNLSRLV VRPHTDAVYH ACFSQDGQRI ASCGADKTLQ VFKAETGEKL LDIKAHEDEV LCCAFSSDDS YIATCSADKK VKIWDSATGK LVHTYDEHSE QVNCCHFTNK SNHLLLATGS NDFFLKLWDL NQKECRNTMF GHTNSVNHCR FSPDDELLAS CSADGTLRLW DVRSANERKS INVKRFFLSS EDPPEDVEVI VKCCSWSADG DKIIVAAKNK VLLFDIHTSG LLAEIHTGHH STIQYCDFSP YDHLAVIALS QYCVELWNID SRLKVADCRG HLSWVHGVMF SPDGSSFLTA SDDQTIRVWE TKKVCKNSAI VLKQEIDVVF QENETMVLAV DNIRGLQLIA GKTGQIDYLP EAQVSCCCLS PHLEYVAFGD EDGAIKIIEL PNNRVFSSGV GHKKAVRHIQ FTADGKTLIS SSEDSVIQVW NWQTGDYVFL QAHQETVKDF RLLQDSRLLS WSFDGTVKVW NVITGRIERD FTCHQGTVLS CAISSDATKF SSTSADKTAK IWSFDLLSPL HELKGHNGCV RCSAFSLDGI LLATGDDNGE IRIWNVSDGQ LLHSCAPISV EEGTATHGGW VTDVCFSPDS KTLVSAGGYL KWWNVATGDS SQTFYTNGTN LKKIHVSPDF RTYVTVDNLG ILYILQVLE //